Cargando…

The therapeutic potential of synthetic human atrial natriuretic peptide in nephrotic syndrome: a randomized controlled trial

BACKGROUND: In nephrotic syndrome, the combination of furosemide and albumin infusion is a standard regimen to treat systemic edema. The efficacy of synthetic human atrial natriuretic peptide (hANP) for nephrotic syndrome to ameliorate the systemic edema and retain renal functions has not been fully...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanzaki, Motoko, Wada, Jun, Kikumoto, Yoko, Akagi, Shigeru, Nakao, Kazushi, Sugiyama, Hitoshi, Makino, Hirofumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379862/ https://www.ncbi.nlm.nih.gov/pubmed/22723729 http://dx.doi.org/10.2147/IJNRD.S32191

Ejemplares similares

Changes of Atrial Natriuretic Peptide Level in Patients with Nephrotic Syndrome after Supine Bicycle Exercise
por: Park, Sung Kwang, et al.
Publicado: (1996)

Long-term effect of cinacalcet hydrochloride on abdominal aortic calcification in patients on hemodialysis with secondary hyperparathyroidism
por: Nakayama, Kazunori, et al.
Publicado: (2013)

Vector synthesis high‐resolution electrocardiography, atrial natriuretic peptide and N‐terminal prohormone brain natriuretic peptide for estimation of cardiac load in pregnancy
por: Tanaka, Shino, et al.
Publicado: (2016)

Atrial Natriuretic Peptide and Adiponectin Interactions in Man
por: Birkenfeld, Andreas L., et al.
Publicado: (2012)

Natriuretic peptides for the detection of paroxysmal atrial fibrillation
por: Seegers, Joachim, et al.
Publicado: (2015)

Awareness of atrial fibrogenesis and natriuretic peptide release
por: Meijers, W. C. F. W., et al.
Publicado: (2017)

Suppression of Adiponectin by Aberrantly Glycosylated IgA1 in Glomerular Mesangial Cells In Vitro and In Vivo
por: Inoue, Tatsuyuki, et al.
Publicado: (2012)

Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy
por: Matsumoto, Shingo, et al.
Publicado: (2020)

Atrial Natriuretic Peptide(31–67): A Novel Therapeutic Factor for Cardiovascular Diseases
por: da Silva, Gustavo Jose Justo, et al.
Publicado: (2021)

Natriuretic peptides: Diagnostic and therapeutic use
por: Pandit, Kaushik, et al.
Publicado: (2011)

Chronic natriuretic peptide protein therapeutics
por: Chen, Horng H, et al.
Publicado: (2013)

Innovative Therapeutics: Designer Natriuretic Peptides
por: Meems, Laura M.G., et al.
Publicado: (2016)

Atrial natriuretic peptide and leptin interactions in healthy men
por: Daniels, Martin A., et al.
Publicado: (2023)

The serum vaspin levels are reduced in Japanese chronic hemodialysis patients
por: Inoue, Junko, et al.
Publicado: (2012)

Atrial Natriuretic Peptide: A Molecular Target of Novel Therapeutic Approaches to Cardio-Metabolic Disease
por: Cannone, Valentina, et al.
Publicado: (2019)

Ratio of preoperative atrial natriuretic peptide to brain natriuretic peptide predicts the outcome of the maze procedure in mitral valve disease
por: Sato, Masafumi, et al.
Publicado: (2013)

Is Atrial Natriuretic Peptide (ANP) and Natriuretic Peptide Receptor-A (NPR-A) Expression in Human Placenta and Decidua Normal?
por: Tan, Hongchuan, et al.
Publicado: (2019)

Low-dose atrial natriuretic peptide for prevention or treatment of acute kidney injury: a systematic review and meta-analysis
por: Yamada, Hiroyuki, et al.
Publicado: (2019)

Role of atrial natriuretic peptide (ANP) in the regulation of insulin secretion and vitality of pancreatic ß cells
por: Tauscher, Sabine, et al.
Publicado: (2015)

Atrial Natriuretic Peptide Induces Postprandial Lipid Oxidation in Humans
por: Birkenfeld, Andreas L., et al.
Publicado: (2008)

N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
por: Thejus, Jayachandran, et al.
Publicado: (2009)

Atrial Natriuretic Peptide in Young and Elderly Children with Mild Gastroenteritis
por: Klar, A., et al.
Publicado: (2009)

Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS
por: Frøssing, Signe, et al.
Publicado: (2017)

Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans
por: Zois, Nora E., et al.
Publicado: (2017)

Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation
por: Baba, Masako, et al.
Publicado: (2019)

Pseudomonas aeruginosa Biofilm Dispersion by the Human Atrial Natriuretic Peptide
por: Louis, Mélissande, et al.
Publicado: (2022)

Associations of atrial natriuretic peptide with measures of insulin and adipose depots
por: Couch, Catharine A., et al.
Publicado: (2023)

Midregional pro-atrial natriuretic peptide, an important member of the natriuretic peptide family: potential role in diagnosis and prognosis of cardiovascular disease
por: Idzikowska, Karolina, et al.
Publicado: (2018)

The level of urinary semaphorin3A is associated with disease activity in patients with minimal change nephrotic syndrome
por: Inoue-Torii, Akiko, et al.
Publicado: (2017)

Inhibition of growth of canine-derived vascular endothelial cells by non-steroidal anti-inflammatory drugs and atrial natriuretic peptide
por: HORIKIRIZONO, Hiro, et al.
Publicado: (2019)

Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis
por: Takiue, Keiichi, et al.
Publicado: (2012)

Atrial Natriuretic Peptide Single Nucleotide Polymorphisms in Patients with Nonfamilial Structural Atrial Fibrillation
por: Francia, Pietro, et al.
Publicado: (2013)

Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males
por: Skov, Jeppe, et al.
Publicado: (2014)

Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: comparison with B-type natriuretic peptide and other natriuretic peptide forms
por: Takashio, Seiji, et al.
Publicado: (2019)

Augmented expression of cardiac atrial natriuretic peptide system in hypertensive rats.
por: An, M. R., et al.
Publicado: (1999)

Natriuretic peptide-induced hyponatremia in a patient with left atrial myxoma
por: Ramnarain, D, et al.
Publicado: (2011)

Involvement of the atrial natriuretic peptide in cardiovascular pathophysiology and its relationship with exercise
por: de Almeida, Júlio C, et al.
Publicado: (2012)

Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx
por: Chappell, Daniel, et al.
Publicado: (2014)

Associations of plasma atrial natriuretic peptide and electrolyte levels with essential hypertension
por: HU, GUANGMEI, et al.
Publicado: (2013)

Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice
por: Werner, Franziska, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qg8nv43r7pbt28g31p1npot015